Animal vaccines are a type of biological product that are used to prevent or control infectious diseases in animals. Vaccines work by stimulating an immune response in animals, enabling them to develop immunity to the targeted pathogen. Animal vaccines are used in a wide range of animals, including livestock, pets, and wildlife. They are essential for maintaining the health of animal populations, preventing the spread of diseases, and protecting public health by reducing the risk of animal-to-human disease transmission. The global animal vaccines market is likely to register a CAGR of over 7.14% with an incremental growth of USD 5.1 billion during the forecast period 2023-2029.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global animal vaccines market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, technology, and region. The global market for animal vaccines can be segmented by type: livestock vaccines, porcine vaccines, companion animal vaccines, poultry vaccines, aquaculture vaccines. Globally, the companion animal vaccines segment made up the largest share of the animal vaccines market. Animal vaccines market is further segmented by technology: live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, others. The live attenuated vaccines segment captured the largest share of the market in 2022. Based on region, the animal vaccines market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. According to the research, Europe had the largest share in the global animal vaccines market.

The livestock vaccines market is further segmented into bovine vaccines, small ruminant vaccines. The bovine vaccines segment was the largest contributor to the global animal vaccines market in 2022. Furthermore, the companion animal vaccines market has been categorized into canine vaccines, feline vaccines, others. The canine vaccines segment is estimated to account for the largest share of the global animal vaccines market.

Market Segmentation
By type: livestock vaccines, porcine vaccines, companion animal vaccines, poultry vaccines, aquaculture vaccines
By technology: live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides a detailed analysis of several leading animal vaccines market vendors that include Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Laboratorios HIPRA SA, Merck & Co., Inc., Neogen Corporation, Phibro Animal Health Corporation, Virbac SA, Zoetis Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
• To analyze and forecast the market size of the global animal vaccines market.
• To classify and forecast the global animal vaccines market based on type, technology, region.
• To identify drivers and challenges for the global animal vaccines market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global animal vaccines market.
• To identify and analyze the profile of leading players operating in the global animal vaccines market.

Why Choose This Report
• Gain a reliable outlook of the global animal vaccines market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.